2000
DOI: 10.2165/00044011-200020030-00008
|View full text |Cite
|
Sign up to set email alerts
|

A Case of Rhabdomyolysis due to Levofloxacin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
13
0

Year Published

2001
2001
2018
2018

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(14 citation statements)
references
References 5 publications
1
13
0
Order By: Relevance
“…in 1996 [1]. Levofloxacin-induced rhabdomyolysis was first reported in 2000 and thus far only a few cases have been reported [47]. Previous reports that rhabdomyolysis occurs within 6 days of initiation of levofloxacin remained true in our case also.…”
Section: Discussionsupporting
confidence: 60%
See 1 more Smart Citation
“…in 1996 [1]. Levofloxacin-induced rhabdomyolysis was first reported in 2000 and thus far only a few cases have been reported [47]. Previous reports that rhabdomyolysis occurs within 6 days of initiation of levofloxacin remained true in our case also.…”
Section: Discussionsupporting
confidence: 60%
“…Management is by stopping the offending agent along with adequate hydration to prevent acute renal failure. Systemic steroids although reported to have a beneficial effect, were not used in this case due to lack of scientific evidence [7]. …”
Section: Discussionmentioning
confidence: 99%
“…This case report highlights levofloxacin as a rare cause of rhabdomyolysis. There have been several other case reports of levofloxacin causing rhabdomyolysis in nondialysis 3,4 or renal transplant recipients. 5 Some of these cases were much more severe than ours, resulting in some of the poor outcomes of rhabdomyolysis, such as acute renal failure, anuria, metabolic acidosis, fatal hyperkalemia and compartment syndromes.…”
Section: Discussionmentioning
confidence: 99%
“…1,7 The fluoroquinolone antibiotics (e.g., ciprofloxacin) also have been reported to be associated with musculoskeletal adverse events such as tendinopathy and tendon rupture, and may increase the risk for rhabdomyolysis due to muscle toxicity. [8][9][10] The risk of statinassociated myopathy has been described as dose dependent. 2,3 Results of a placebo-controlled clinical trial of cerivastatin, for example, showed that the rate of CK elevations in patients taking cerivastatin was greater compared to other statin therapies and dependent on dosage.…”
Section: Introductionmentioning
confidence: 99%